MicroStrategy
MSTR
Tesla
TSLA
MARA Holdings
MARA
Coinbase
COIN
Amazon
AMZN
US Stock MarketDetailed Quotes
OPK Opko Health
- 1.510
- 0.0000.00%
Close Dec 24 13:00 ET
- 1.510
- 0.0000.00%
Post 16:54 ET
1.02BMarket Cap-7.95P/E (TTM)
1.530High1.490Low1.41MVolume1.500Open1.510Pre Close2.13MTurnover0.55%Turnover RatioLossP/E (Static)672.80MShares1.76052wk High0.72P/B386.61MFloat Cap0.85252wk Low--Dividend TTM256.04MShs Float19.200Historical High--Div YieldTTM2.65%Amplitude0.210Historical Low1.512Avg Price1Lot Size
About Opko Health Company
OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
Company Profile
SymbolOPK
Company NameOpko Health
Listing DateJun 24, 2016
Founded1991
CEODr. Phillip Frost, M.D.
MarketNASDAQ
Employees3930
Fiscal Year Ends12-31
Address4400 Biscayne Boulevard
CityMiami
ProvinceFlorida
CountryUnited States of America
Zip Code33137
Phone1-305-575-4100
Websitehttp://www.opko.com
Company Executives
- Name
- Position
- Salary
- Dr. Tony F. Cruz
- Chief Executive Officer of Transition Therapeutics
- --
- Dr. Phillip Frost, M.D.
- Chairman of the Board and Chief Executive Officer
- 2.28M
- Charles W Bishop, Pd.D
- Chief Executive Officer, OPKO Renal
- --
- Adam E. Logal
- Senior Vice President, Chief Financial Officer, Chief Accounting Officer and Treasurer
- 1.81M
- Dr. Gary J. Nabel, M.D.,PhD
- Chief Innovation Officer and Director
- --
- Dr. Jane H. Hsiao, M.B.A.,PhD
- Vice Chairman of the Board and Chief Technical Officer
- 2.19M
- Steven D. Rubin
- Director and Executive Vice President, Administration
- 1.94M
- Dr. Elias A. Zerhouni, M.D.
- President and Vice Chairman of the Board
- 2.19M
- Dr. Alice Lin-Tsing Yu, M.D.,PhD
- Independent Director
- 62.40K
- Dr. Roger J. Medel,M.D.
- Independent Director
- 69.90K
- Dr. Richard M. Krasno, PhD
- Independent Director
- 92.40K
- Richard C. Pfenniger, Jr
- Lead Independent Director
- 134.80K
- John A. Paganelli
- Independent Director
- 84.90K
- Dr. Prem A. Lachman, M.D.
- Independent Director
- 92.40K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.